Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00139451 · ClinicalTrials.gov registry record · Phase 2

Nutrients and Hormones: Effects in Boys With Disordered Growth

A Phase 2 study, sponsored by Nemours Children's Clinic.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target

NCT00139451: Completed Phase 2 study, sponsored by Nemours Children's Clinic.

NCT00139451 is a Phase 2 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00139451, a Phase 2 study, has completed, sponsored by Nemours Children's Clinic.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target

Study Summary

The purpose of the study is to find out if patients with constitutional delay of growth have a mismatch between energy intake and utilization (as measured by doubly labeled water) and to compare the improvement in growth and energy balance between a group of boys treated with growth hormone (GH) alone versus those given GH plus added nutritional supplements for one year.

Interventions

  • DRUG Pediasure
  • DRUG GH

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2004-05
Est. Completion 2010-09
Phase Phase 2
Nemours Children's Clinic

108 total trials

What the finished NCT00139451 record still lists

NCT00139451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Pediasure is the first listed.

NCT00139451 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00139451 about?

NCT00139451 is a clinical study titled "Nutrients and Hormones: Effects in Boys With Disordered Growth". The purpose of the study is to find out if patients with constitutional delay of growth have a mismatch between energy intake and utilization (as measured by doubly labeled water) and to compare the improvement in growth and energy balance between a group of boys treated with growth hormone (GH) alo...

What is the current status of trial NCT00139451?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2004-05. Estimated completion is 2010-09.

What interventions are being tested in trial NCT00139451?

The interventions under investigation include: Pediasure (DRUG), GH (DRUG).

Who is sponsoring clinical trial NCT00139451?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00139451's enrollment target sits among peer trials

20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00139451, the US trial registry maintained by the National Library of Medicine. NCT00139451 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.